We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

1 hedge funds and large institutions have $34.3M invested in Ariad Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 191 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding in top 10

Funds holding in top 10: 9 → 1 (-8)

98% less capital invested

Capital invested by funds: $2.13B → $34.3M (-$2.09B)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 191

100% less funds holding

Funds holding: 200 → 1 (-199)

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
191
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$16.5M

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$225M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$218M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$182M
4
SCM
Sarissa Capital Management
Connecticut
-$160M
5
State Street
State Street
Massachusetts
-$97.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
76
First Trust Advisors
Illinois
– -$2.05M -165,020 Closed
PIM
77
Platinum Investment Management
Australia
– -$2.05M -164,700 Closed
ProShare Advisors
78
ProShare Advisors
Maryland
– -$1.95M -156,720 Closed
AIMCA
79
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$1.79M -144,170 Closed
Principal Financial Group
80
Principal Financial Group
Iowa
– -$1.78M -142,761 Closed
PPA
81
Parametric Portfolio Associates
Washington
– -$1.76M -141,892 Closed
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
– -$1.62M -130,410 Closed
MLICM
83
Metropolitan Life Insurance Company (MetLife)
New York
– -$1.55M -124,544 Closed
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1.49M -120,164 Closed
TD Asset Management
85
TD Asset Management
Ontario, Canada
– -$1.43M -115,003 Closed
AR
86
Advisory Research
Illinois
– -$1.33M -106,578 Closed
DekaBank Deutsche Girozentrale
87
DekaBank Deutsche Girozentrale
Germany
– -$1.31M -104,100 Closed
AIG
88
American International Group
New York
– -$1.27M -101,756 Closed
FM
89
Family Management
New York
– -$1.24M -100,000 Closed
SG Americas Securities
90
SG Americas Securities
New York
– -$1.17M -93,615 Closed
LCM
91
Landscape Capital Management
New Jersey
– -$1.01M -81,003 Closed
UBS AM
92
UBS AM
Illinois
– -$981K -78,804 Closed
GTC
93
Ghost Tree Capital
New York
– -$933K -75,000 Closed
VEA
94
Virtus ETF Advisers
New York
– -$929K -74,688 Closed
VOYA Investment Management
95
VOYA Investment Management
Georgia
– -$925K -74,396 Closed
Canada Pension Plan Investment Board
96
Canada Pension Plan Investment Board
Ontario, Canada
– -$888K -71,400 Closed
Bank of America
97
Bank of America
North Carolina
– -$846K -67,923 Closed
PAM
98
Panagora Asset Management
Massachusetts
– -$830K -66,707 Closed
Legal & General Group
99
Legal & General Group
United Kingdom
– -$820K -65,954 Closed
LCG
100
Lisanti Capital Growth
New York
– -$818K -65,750 Closed
2 3
4
5 6

ARIA Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2017, worth a combined $34.3M — down 98% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 191 funds closed out of ARIA and 1 opened new positions — a net loss of 190 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $225M sold.

  • 1 institutional investor held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2017, down from 200 in Q4 2016.
  • Funds reported $34.3M of Ariad Pharmaceuticals Inc stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Ariad Pharmaceuticals Inc positions in Q1 2017 and 191 closed out, a net change of -190 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $32M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $225M sold.

Based on aggregated 13F filings for Q1 2017.